Telesis Bio Total Liabilities

Telesis Bio (TBIO) currently reports a total liabilities of $21M as of September 2024. That compares with $59M in the prior-year period — down 64.4% year over year. Use the charts on this page to explore Telesis Bio's total liabilities history and peer comparisons.

Telesis Bio's total liabilities decreased from $59M to $21M — a 64.4% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Telesis Bio reported $21M in total liabilities as of September 2024. That compares with $59M in the prior-year period — down 64.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Telesis Bio, and consider following TBIO for alerts when major investors trade the stock.

Telesis Bio is classified in the Healthcare sector. On total liabilities, it currently shows $21M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TBIO with unrelated industries.